Individuals with IBD have a higher risk of developing pulmonary diseases such as COPD and asthma. A novel method uses tumor-specific profiling to detect antibodies which are unique to early-stage melanoma. Infants fed exclusively breast milk during their hospitalization at birth are less likely to develop childhood asthma. BridgeBio Pharma announced this week outcomes from the ATTRibute-CM study will be shared at AHA 2024. A study identified possible prognostic factors and survival patterns based on histology type in endometrial cancer patients. Two UCF researchers were bestowed state grants to support their innovative projects to fight breast cancer. Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease. The renowned Dr. Emanuel Mignot spoke about the importance of personalized care for persons living with narcolepsy. A study demonstrated long-term safety and efficacy of the GORE CARDIOFORM ASD Occluder. Matt Davis, MD, compared current therapies in narcolepsy and provides key takeaways from the WUN gala. Richard Kim of Avadel talks about the "exciting" future of narcolepsy care. Bridge Bio Pharma presented results from a post-hoc analysis which demonstrated the efficacy of acoramidis in ATTR-CM. Researchers have discovered that Crohn disease is comprised of two distinct molecular subtypes. A two-dose schedule administered just one week apart can potentially increase the efficacy of an HIV vaccine. Théophile Mohr-Durdez, CEO and co-founder of Volta Medical, talks about streamlining workflows for electrophysiologists. Dr. Kiran Maski was presented with the Research Pioneer Award at the WUN Shadows to Light gala. Jennifer Gudeman talks about the significance of the WUN Shadows to Light gala and role Avadel plays in treating narcolepsy. Oral bacteria are a risk factor for head and neck squamous cell cancer. Cancer incidence trends in 2021 mostly returned to their pre-COVID-19 pandemic levels, with the exception of breast cancer. A study analyzed the correlation between cancer-related cognitive impairment and neurotransmission pathways.